Ed Tate is Professor of Chemical Biology and holds the GSK Chair in Chemical Biology in the Department of Chemistry at Imperial College London. He also serves as a Satellite Group Leader at the Francis Crick Institute. He earned a BSc in chemistry from the University of Durham and a PhD in organic chemistry and methodology from the University of Cambridge under Professor Steve Ley. Following his doctorate, he completed postdoctoral work at the Ecole Polytechnique in Paris with Professor Sam Zard on an 1851 Research Fellowship, focusing on radical chemistry and natural product synthesis, and at the Institut Pasteur with a Howard Trust Research Fellowship on molecular microbiology.
At Imperial College London, Tate advanced through appointments as a BBSRC David Phillips Research Fellow in 2006, Senior Lecturer in 2010, Reader in Chemical Biology in 2012, and Professor of Chemical Biology in 2014. He is a Fellow of the Royal Society of Chemistry and the Royal Society of Biology, and Director of Imperial’s Centre for Drug Discovery Science as well as the MRes programme in Drug Discovery and Development. His research focuses on chemical biology and chemical proteomics at the interface of organic chemistry, life sciences, and medicine. Tate has received numerous awards, including the Wain Medal in 2012, the MedImmune Protein and Peptide Science Award in 2013, the Norman Heatley Award in 2014, a Cancer Research UK Programme Foundation Award in 2015, the Sir David Cooksey Translation Prize in 2019, and the Corday-Morgan Prize in 2020. He founded and served as CSO of Myricx Pharma Ltd.